ArticleWorld journal of gastroenterology2025
SinglePass Kronos electrocautery device for closure after percutaneous medical liver biopsy: Five case reports.
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- SinglePass Kronos Electrocautery Device for Closure After Percutaneous Medical Kidney Biopsy: A Series of Five Case Reports.Kidney medicine · 2026Article
- SinglePass electrocautery device for closure of lung and mediastinal biopsy: a case series of 5 patients.Frontiers in oncology · 2026Article
- SinglePass Kronos electrocautery device for closure of liver mass image-guided biopsy: a series of five case reports.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPercutaneous liver biopsies, including coaxial needle biopsy (CNB), are the preferred method for tissue sampling to diagnose or characterize an array of hepatic conditions. Despite the advent of intraprocedural image guidance, and various "plugging" techniques, bleeding remains a frequent and potentially highly morbid complication, particularly in patients with bleeding risks. Thus, post-biopsy bleeding risk leads to extended patient monitoring, and in significant cases, additional imaging, intervention, and even surgery. Very rarely, death has resulted. CASE SUMMARY: We report a series of five image-guided liver biopsy cases undertaken due to a variety of clinical conditions followed by the use of a new electrocautery hemostasis device called SinglePass Kronos. Indications for the CNB included non-alcoholic steatohepatitis, hepatocellular carcinoma and cirrhosis, abnormal liver function tests with positive autoimmune serologies, abnormal imaging findings, and jaundice. All biopsy procedures were successful with no complications through 30 days following CNB. Post-procedure ultrasound confirmed the absence of bleeding in all five cases.
conclusionHemostasis of CNB tracts using SinglePass Kronos was obtained in all cases. Additional study of this device is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.